No Additional Royalties Sample Clauses

No Additional Royalties. In the event that IndianRaga receives revenue from licenses and/or sale of rights in or to the Participant Content, IndianRaga will keep all revenues and is under no obligation to pay any fee or royalty to the Participant. IndianRaga is under no obligation to charge fees for its licenses or sale of Performances or Recordings.
View SourceView Similar (5)
No Additional Royalties. To the best of Isis’ knowledge, Archemix will have no obligation to make any royalty or other payment to any Third Party as a result of the grant by Isis to Archemix of the licenses set forth in Section 2.1.1 or 2.2.1.
View SourceView Similar (2)
No Additional Royalties. The Parties acknowledge and agree that the only payments to be made by SutroVax to Sutro, directly or indirectly, in consideration for the rights licensed under Section 4.1(a), with respect to Vaccine Compositions will be the royalties and Net Sublicense Fees specified in Article 6 of this Agreement. Accordingly, Sutro shall not charge additional royalties or other similar payments in consideration for such rights from any CMO engaged or approved by Sutro pursuant to Section 3.1 or 3.2 with respect to the supply of Extracts or Vaccine Compositions (as applicable) which would flow through to SutroVax on Extracts or Vaccine Compositions supplied by such CMO to SutroVax, its Affiliates or Sublicensees (as applicable). For clarity, this Section 3.4 shall not be construed to prevent or restrict Sutro from charging the applicable CMO and/or SutroVax a reasonable transfer price (with respect to supply to SutroVax, subject to the applicable price set forth in Section 3.1) for the supply of Extract following the Series A Financing Close.
View SourceView Similar (2)
No Additional Royalties. ▇▇▇▇▇▇▇▇▇ expressly agrees that the promotional efforts agreed to by Company, pursuant to Paragraph 2 of this Addendum, constitutes sufficient consideration for this Addendum to the Agreement and that the royalties provided by the Agreement will remain unchanged with no additional royalties being required for license of the name "▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇" and picture of ▇▇▇▇▇▇▇▇▇ and the other amendments to the Agreement provided by this Addendum, except that Subsection 4.1(b) and Section 4.2 shall be deleted in their entirety and restated as follows, and said Agreement shall be interpreted and effected as if the following restated provisions had been present since April 17, 1993; (b) The Company will pay ▇▇▇▇▇▇▇▇▇ percentage royalties (the "Percentage Royalties"), as set forth in the following table, on the cumulative NET SALES PRICE OF PRODUCTS AND ADDITIONAL PRODUCTS sold by the Company: Cumulative NET SALES PRICE OF ALL PRODUCTS Royalty Percentage $0 to $1,000,000 8% Over $1,000,000 9% 4.2 Within fifteen (15) days after the close of each fiscal quarter from and after July 1, 1993, the Company will pay ▇▇▇▇▇▇▇▇▇ the Royalties due on all PRODUCTS and ADDITIONAL PRODUCTS sold during the preceding quarter. For purposes of calculating the Royalties due to ▇▇▇▇▇▇▇▇▇, any Advance Royalties paid to ▇▇▇▇▇▇▇▇▇ will be deducted from the Percentage Royalties payable to ▇▇▇▇▇▇▇▇▇. No Percentage Royalties shall be paid to ▇▇▇▇▇▇▇▇▇ until the product of the Net Sales Price of all PRODUCTS and ADDITIONAL PRODUCTS (sold) times the (applicable) Royalty Percentage exceeds the sum of all paid Royalty Advances.
View Source
No Additional Royalties. Except as set forth in Section 5.2(a)(iv) hereof, NCT shall not be entitled to any additional royalties, other than the royalties described in and referred to in Section 3.2(a) hereof, if QuietPower exercises its right to manufacture an Active System itself or sublicense its manufacture.
View Source

Related to No Additional Royalties

  • Earned Royalties In partial consideration of the License and subject to Sections 3.7 and 3.8, Company will pay to Penn: (i) a graduated royalty as set forth in the table below based upon worldwide annual Net Sales made by Company and its Affiliates (but not sublicensees) of any Designated Compound Sold for use in the Field of Use while covered in the country of Sale of expected use by a Valid Claim of the Assigned BMS Patents that is licensed to Company under the License (but no other Licensed Product): <$500 million [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$500 million but <$750 million [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$750 million but <$1 billion [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$1 billion [CONFIDENTIAL TREATMENT REQUESTED] /*/% [CONFIDENTIAL TREATMENT REQUESTED] /*/ PATENT LICENSE AGREEMENT (ii) a royalty of [CONFIDENTIAL TREATMENT REQUESTED] /*/ percent ([CONFIDENTIAL TREATMENT REQUESTED] /*/%) of Net Sales made by Company and its Affiliates (but not sublicensees) for all Licensed Products that qualify as “Licensed Products” hereunder based on clause (b) of that definition and Sold while covered in the country of Sale of expected use by a Valid Claim of the Penn Existing Patents or Penn New Patents; provided that, notwithstanding any credits provided for in Section 3.7 but subject in all events to Section 3.8, royalties payable by Company for such Net Sales for such Licensed Products shall not be less than [CONFIDENTIAL TREATMENT REQUESTED] /*/ percent ([CONFIDENTIAL TREATMENT REQUESTED] /*/%). Only one royalty shall be due hereunder on the Sale of the same unit of Licensed Product. If a royalty accrues to a Sale of a Licensed Product under both clause (i) and (ii) above, then the higher rate of clause (i) shall apply. Only one royalty shall be due hereunder on the Sale of a Licensed Product even if the manufacture, use, sale, offer for sale or importation of such Licensed Product infringes more than one Valid Claim of the Penn Patent Rights.

  • Payment of Royalties To the best of Seller’s knowledge, all royalties and in-lieu royalties with respect to the Assets which accrued or are attributable to the period prior to the Effective Time have been properly and fully paid, or are included within the suspense amounts being conveyed to Buyer pursuant to Section 11.4.

  • License Fees and Royalties Consistent with the applicable U.S. DOT Common Rules, the Recipient agrees that license fees and royalties for patents, patent applications, and inventions produced with federal assistance provided through the Underlying Agreement are program income, and must be used in compliance with federal applicable requirements.

  • Minimum Royalties If royalties paid to Licensor do not reach the minimum royalty amounts stated in Section 3.3 of the Patent & Technology License Agreement for the specified periods, Licensee will pay Licensor on or before the Quarterly Payment Deadline for the last Contract Quarter in the stated period an additional amount equal to the difference between the stated minimum royalty amount and the actual royalties paid to Licensor.

  • Running Royalties Company shall pay to JHU a running royalty as set forth in Exhibit A, for each LICENSED PRODUCT(S) sold, and for each LICENSED SERVICE(S) provided, by Company or AFFILIATED COMPANIES, based on NET SALES and NET SERVICE REVENUES for the term of this Agreement. Such payments shall be made quarterly. All non-US taxes related to LICENSED PRODUCT(S) or LICENSED SERVICE(S) sold under this Agreement shall be paid by Company and shall not be deducted from royalty or other payments due to JHU. In order to insure JHU the full royalty payments contemplated hereunder, Company agrees that in the event any LICENSED PRODUCT(S) shall be sold to an AFFILIATED COMPANY or SUBLICENSEE(S) or to a corporation, firm or association with which Company shall have any agreement, understanding or arrangement with respect to consideration (such as, among other things, an option to purchase stock or actual stock ownership, or an arrangement involving division of profits or special rebates or allowances) the royalties to be paid hereunder for such LICENSED PRODUCT(S) shall be based upon the greater of: 1) the net selling price (per NET SALES) at which the purchaser of LICENSED PRODUCT(S) resells such product to the end user, 2) the NET SERVICE REVENUES received from using the LICENSED PRODUCT(S) in providing a service, or 3) the net selling price (per NET SALES) of LICENSED PRODUCT(S) paid by the purchaser. No multiple royalties shall be due or payable because any LICENSED PRODUCT(S) or LICENSED SERVICE(S) is covered by more than one claim of the PATENT RIGHTS or by claims of both the PATENT RIGHTS under this Agreement and “PATENT RIGHTS” under any other license agreement between Company and JHU. The royalty shall not be cumulative based on the number of patents or claims covering a product or service, but rather shall be capped at the rate set forth in Exhibit A.